pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
Hubs
  • Topics
  • Patent cliff
  • Publications
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search

calendar

7,970 catalysts · 5,347 phase readout · 2,277 8k filing · 343 pdufa · 257 earnings · 2 approval · 1 adcom

★ save view↓export CSV
next 91 dayslessmore
MonWedFri
2026-08-03: 4 catalysts2026-08-04: 13 catalysts2026-08-05: 18 catalysts2026-08-06: 11 catalysts2026-08-07: 1 catalyst2026-08-08: 0 catalysts2026-08-09: 0 catalysts2026-08-10: 2 catalysts2026-08-11: 1 catalyst2026-08-12: 2 catalysts2026-08-13: 1 catalyst2026-08-14: 1 catalyst2026-08-15: 0 catalysts2026-08-16: 0 catalysts2026-08-17: 0 catalysts2026-08-18: 1 catalyst2026-08-19: 0 catalysts2026-08-20: 0 catalysts2026-08-21: 0 catalysts2026-08-22: 0 catalysts2026-08-23: 0 catalysts2026-08-24: 0 catalysts2026-08-25: 0 catalysts2026-08-26: 0 catalysts2026-08-27: 0 catalysts2026-08-28: 0 catalysts2026-08-29: 0 catalysts2026-08-30: 0 catalysts2026-08-31: 0 catalysts2026-09-01: 1 catalyst2026-09-02: 0 catalysts2026-09-03: 0 catalysts2026-09-04: 0 catalysts2026-09-05: 0 catalysts2026-09-06: 0 catalysts2026-09-07: 0 catalysts2026-09-08: 0 catalysts2026-09-09: 0 catalysts2026-09-10: 0 catalysts2026-09-11: 0 catalysts2026-09-12: 0 catalysts2026-09-13: 0 catalysts2026-09-14: 0 catalysts2026-09-15: 0 catalysts2026-09-16: 0 catalysts2026-09-17: 0 catalysts2026-09-18: 0 catalysts2026-09-19: 0 catalysts2026-09-20: 0 catalysts2026-09-21: 0 catalysts2026-09-22: 0 catalysts2026-09-23: 0 catalysts2026-09-24: 0 catalysts2026-09-25: 0 catalysts2026-09-26: 0 catalysts2026-09-27: 0 catalysts2026-09-28: 0 catalysts2026-09-29: 0 catalysts2026-09-30: 0 catalysts2026-10-01: 0 catalysts2026-10-02: 0 catalysts2026-10-03: 0 catalysts2026-10-04: 0 catalysts2026-10-05: 0 catalysts2026-10-06: 0 catalysts2026-10-07: 0 catalysts2026-10-08: 0 catalysts2026-10-09: 0 catalysts2026-10-10: 0 catalysts2026-10-11: 0 catalysts2026-10-12: 0 catalysts2026-10-13: 0 catalysts2026-10-14: 0 catalysts2026-10-15: 0 catalysts2026-10-16: 0 catalysts2026-10-17: 0 catalysts2026-10-18: 0 catalysts2026-10-19: 0 catalysts2026-10-20: 1 catalyst2026-10-21: 1 catalyst2026-10-22: 2 catalysts2026-10-23: 0 catalysts2026-10-24: 0 catalysts2026-10-25: 0 catalysts2026-10-26: 0 catalysts2026-10-27: 2 catalysts2026-10-28: 1 catalyst2026-10-29: 3 catalysts2026-10-30: 0 catalysts2026-10-31: 0 catalysts2026-11-01: 0 catalysts
view
agendamonth
show past →
sort
soonestlatesttypesponsoralpha
type
  • phase readout5,347
  • 8k filing2,277
  • pdufa343
  • earnings257
  • approval2
  • adcom1
therapy area

no tagged catalysts yet

Date TBD

50
›RECRUITINGphase readoutNCT05830058: Positron Emission Tomography (PET) Guided Stereotactic Body Radiation Therapy for the Treatment of Oligoprogressive Non-small Cell Lung Cancer, Melanoma, and Renal Cell Carcinoma

Sponsor: City of Hope Medical Center. Phase: PHASE2. Conditions: Lung Non-Small Cell Carcinoma, Malignant Solid Neoplasm, Melanoma, Renal Cell Carcinoma

full page →ctgov ↗
›ACTIVE_NOT_RECRUITINGphase readoutNCT07430748: REGENFAST vs L-PRF in Periodontal Regeneration

Sponsor: University of Santiago de Compostela. Phase: EARLY_PHASE1. Conditions: Regeneration, Periodontal Defects, Biomaterials

full page →ctgov ↗
›COMPLETEDphase readoutNCT02453048: Study of BPZE1 (High Dose) Nasal Live Attenuated B. Pertussis Vaccine

Sponsor: Institut National de la Santé Et de la Recherche Médicale, France. Phase: PHASE1. Conditions: Pertussis, Whooping Cough

full page →ctgov ↗
›RECRUITINGphase readoutNCT07299955: A Phase 1 Comparative Study to Evaluate Pharmacokinetics, Immunogenicity, Safety and Tolerability of Bmab3000 and Herceptin Hylecta® After a Single 600 mg SC Injection in Healthy Male Volunteers

Sponsor: Biocon Biologics UK PLC. Phase: PHASE1. Conditions: Healthy Male Participants

full page →ctgov ↗
›COMPLETEDphase readoutNCT04926285: Safety and Efficacy of Venetoclax With Escalating Doses of Omacetaxine in Patients With Acute Myeloid Leukemia Safety and Efficacy of Venetoclax With Escalating Doses of Omacetaxine in Patients With Acute Myeloid Leukemia (AML)

Sponsor: University of Illinois at Chicago. Phase: PHASE1. Conditions: Relapsed or Refractory Hematologic Malignancies

full page →ctgov ↗
›RECRUITINGphase readoutNCT07144085: Application of ⁶⁸Ga-FXX489 (NNS309) PET/CT Imaging in Diagnosis of Tumor Diseases.

Sponsor: Yi Tian. Phase: PHASE1. Conditions: Tumor, Metastatic Cancer

full page →ctgov ↗
›ACTIVE_NOT_RECRUITINGphase readoutNCT04649385: BGB-15025 Alone and in Combination With Anti-PD-1 Monoclonal Antibody Tislelizumab in Participants With Advanced Solid Tumors

Sponsor: BeiGene. Phase: PHASE1. Conditions: Advanced Solid Tumor

full page →ctgov ↗
›NOT_YET_RECRUITINGphase readoutNCT07557485: Randomized Clinical Trial of Endovascular Treatment for Progressive Stroke With Vertebrobasilar Artery Occlusion

Sponsor: Feng Gao. Phase: NA. Conditions: Vertebrobasilar Artery Occlusion, Endovascular Treatment

full page →ctgov ↗
›ACTIVE_NOT_RECRUITINGphase readoutNCT04578938: Ketamine + Cognitive Training for Suicidality in the Medical Setting

Sponsor: Rebecca Price. Phase: PHASE4. Conditions: Suicide, Attempted

full page →ctgov ↗
›NOT_YET_RECRUITINGphase readoutNCT07558915: A Study to Evaluate RO7851624 in Participants With Relapsed/Refractory Multiple Myeloma (RRMM)

Sponsor: Genentech, Inc.. Phase: PHASE1. Conditions: Relapsed/Refractory Multiple Myeloma

full page →ctgov ↗
›RECRUITINGphase readoutNCT07426315: Innovative Methodologies for Neuroplasticity in Developmental Age With the Use of Virtual Reality

Sponsor: IRCCS Centro Neurolesi Bonino Pulejo. Phase: NA. Conditions: Neurodevelopmental Disorders

full page →ctgov ↗
›COMPLETEDphase readoutNCT04620915: Construal Level as a Novel Pathway for Affect Regulation and Cancer Control

Sponsor: University of Oregon. Phase: NA. Conditions: Smoking Cessation, Smoking Reduction, Cancer

full page →ctgov ↗
›WITHHELDphase readoutNCT06658015: [Trial of device that is not approved or cleared by the U.S. FDA]

Sponsor: [Redacted]. Phase: . Conditions:

full page →ctgov ↗
›ACTIVE_NOT_RECRUITINGphase readoutNCT05928325: Geriatric Care Survivorship Intervention for Improving the Overall Health of Older Adults With Stage I-III Breast Cancer Who Have Completed Curative Treatment

Sponsor: M.D. Anderson Cancer Center. Phase: NA. Conditions: Anatomic Stage I Breast Cancer AJCC v8, Anatomic Stage II Breast Cancer AJCC v8, Anatomic Stage III Breast Cancer AJCC v8

full page →ctgov ↗
›COMPLETEDphase readoutNCT06135740: Impact of Nutrition, Sleep, and Physical Activity on Intellectual Function and Muscle Mass in Older Adults

Sponsor: Tokyo University. Phase: NA. Conditions: Cognition Disorders in Old Age, Cognitive Function, Frailty/Sarcopenia, MCI

full page →ctgov ↗
›COMPLETEDphase readoutNCT04089189: Study of IMP4297 in Patients With BRCA1/2 Mutation Ovarian Cancer

Sponsor: Impact Therapeutics, Inc.. Phase: PHASE2. Conditions: Ovarian Cancer

full page →ctgov ↗
›NOT_YET_RECRUITINGphase readoutNCT07548489: Phenobarbital for Agitated Delirium

Sponsor: Duke University. Phase: PHASE3. Conditions: Agitated Delirium, Delirium Confusional State, Delirium in the Intensive Care Unit, Hyperactive Delirium

full page →ctgov ↗
›NOT_YET_RECRUITINGphase readoutNCT07395050: Autologous CD6-CAR Treg Cells for Patients With Stage 3 Type 1 Diabetes

Sponsor: City of Hope Medical Center. Phase: EARLY_PHASE1. Conditions: Stage 3 Type 1 Diabetes

full page →ctgov ↗
›ACTIVE_NOT_RECRUITINGphase readoutNCT05967468: Evaluation of Family-Based Behavioral Treatments for Youth With Anxiety and Obsessive-Compulsive Disorder

Sponsor: Baylor College of Medicine. Phase: NA. Conditions: Obsessive-Compulsive Disorder in Children, Anxiety Disorder of Childhood, Social Anxiety Disorder of Childhood, Obsessive-Compulsive Disorder in Adolescence, Generalized Anxiety Disorder, Separation Anxiety, Panic Disorder, Panic Disorder With Agoraphobia, Panic Attacks

full page →ctgov ↗
›COMPLETEDphase readoutNCT05849168: High-Intensity Interval Training to Improve Symptoms of Deployment-Related Respiratory Disease

Sponsor: University of Colorado, Denver. Phase: NA. Conditions: Occupational Exposure

full page →ctgov ↗
›RECRUITINGphase readoutNCT03593317: Blockade of the Renin-angiotensin-aldosterone System in Patients With ARVD

Sponsor: Hospices Civils de Lyon. Phase: PHASE2. Conditions: Arrhythmogenic Right Ventricular Dysplasia

full page →ctgov ↗
›NOT_YET_RECRUITINGphase readoutNCT07324291: Perianal MBL-CRE Colonization and Infection in Allogeneic Hematopoietic Stem Cell Transplant Patients

Sponsor: Institute of Hematology & Blood Diseases Hospital, China. Phase: . Conditions: ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION, Carbapenem-resistant Enterobacterales

full page →ctgov ↗
›RECRUITINGphase readoutNCT07426991: Cognitive Performance, Sleep Disturbances and Fatigue in Multiple Sclerosis

Sponsor: Heinrich-Heine University, Duesseldorf. Phase: . Conditions: Multiple Sclerosis, Remitting-Relapsing Multiple Sclerosis, Primary Progressive Multiple Sclerosis, Secondary Progress Multiple Sclerosis, Fatigue Syndrome, Chronic, Sleep Disorders

full page →ctgov ↗
›COMPLETEDphase readoutNCT06948890: Effect of Music on Cue Reactivity for Patients With Opioid Use Disorder

Sponsor: Brigham and Women's Hospital. Phase: NA. Conditions: Opioid Use Disorder

full page →ctgov ↗
›RECRUITINGphase readoutNCT07336797: Effect of Empagliflozin on Metabolic Outcomes in Adults Living With HIV Receiving Dolutegravir-Based Therapy

Sponsor: Abdelrahman Mahmoud. Phase: PHASE2. Conditions: Metabolic Syndrome, Obesity & Overweight, HIV (Human Immunodeficiency Virus)

full page →ctgov ↗
›RECRUITINGphase readoutNCT06435897: Autoimmune Disease Treatment With Mesenchymal Stem Cells (MSCs) and CAR-T Cells

Sponsor: Shenzhen Geno-Immune Medical Institute. Phase: PHASE1. Conditions: Autoimmune Diseases

full page →ctgov ↗
›COMPLETEDphase readoutNCT07453810: Flow- Versus Volume-controlled Ventilation During Robot-assisted Laparoscopic Radical Prostatectomy

Sponsor: Ankara Etlik City Hospital. Phase: NA. Conditions: Positive Pressure Ventilation

full page →ctgov ↗
›RECRUITINGphase readoutNCT06623097: Exercise and Nutrition for Older Cancer Survivors and Their Support Person: The Vitality Study

Sponsor: Dana-Farber Cancer Institute. Phase: NA. Conditions: Cancer Survivorship

full page →ctgov ↗
›ACTIVE_NOT_RECRUITINGphase readoutNCT06069310: Mepolizumab Effectiveness in Patients With Chronic Rhinosinusitis, Nasal Polyps and Comorbid Severe Eosinophilic Asthma

Sponsor: National and Kapodistrian University of Athens. Phase: . Conditions: Chronic Rhinosinusitis With Nasal Polyps, Severe Eosinophilic Asthma, Chronic Rhinosinusitis Without Nasal Polyps

full page →ctgov ↗
›NOT_YET_RECRUITINGphase readoutNCT07379697: Measuring Local Potentials in PFA. MULTI PFA (EU)

Sponsor: CathVision ApS. Phase: . Conditions: Atrial Fibrillation (AF)

full page →ctgov ↗
›NOT_YET_RECRUITINGphase readoutNCT07499310: The Safety and Effectiveness of Q Therapeutic System, Frequency-tuned Electromagnetic Field Treatment in Facilitating the Recovery of Patients With Chronic Stroke.

Sponsor: Kessler Foundation. Phase: NA. Conditions: Stroke, Chronic Stroke Patients

full page →ctgov ↗
›COMPLETEDphase readoutNCT06558513: To Evaluate a Phase I/II Clinical Study of XNW5004 Tablets in Patients With Relapsed/Refractory Advanced Tumors

Sponsor: Evopoint Biosciences Inc.. Phase: PHASE1. Conditions: Advanced Tumor, Lymphoma

full page →ctgov ↗
›COMPLETEDphase readoutNCT00974090: Efficacy and Safety Study of MP-513 in Combination With Sulfonylurea in Patients With Type 2 Diabetes

Sponsor: Tanabe Pharma Corporation. Phase: PHASE3. Conditions: Type 2 Diabetes Mellitus

full page →ctgov ↗
›RECRUITINGphase readoutNCT06398990: The Effect of Cognitive Exercise Therapy Approach and Yoga in Adolescents With Dysmenorrhoea

Sponsor: Acibadem University. Phase: NA. Conditions: Dysmenorrhea, Primary Dysmenorrhea

full page →ctgov ↗
›RECRUITINGphase readoutNCT07389590: Study of Ublituximab for Ocrelizumab Wearing-Off in Multiple Sclerosis

Sponsor: Johns Hopkins University. Phase: PHASE4. Conditions: Multiple Sclerosis

full page →ctgov ↗
›RECRUITINGphase readoutNCT07230990: Mechanisms Of Orbitofrontal Stimulation in Depression

Sponsor: Subha Subramanian. Phase: NA. Conditions: Major Depressive Disorder (MDD)

full page →ctgov ↗
›NOT_YET_RECRUITINGphase readoutNCT06465290: Promoting Neuroplastic Changes of Patients With TBI

Sponsor: University of Maryland, Baltimore. Phase: NA. Conditions: Traumatic Brain Injury

full page →ctgov ↗
›COMPLETEDphase readoutNCT02292160: Does the National Health Insurance Card Allow us to Predict Antibiotic Resistance?

Sponsor: University Hospital, Rouen. Phase: . Conditions: Urinary Tract Infection Empiric Antibiotic

full page →ctgov ↗
›ACTIVE_NOT_RECRUITINGphase readoutNCT04890834: Dyadic Yoga Intervention for the Improvement of Healthcare Utilization and Quality of Life in Patients With Head and Neck Cancer Undergoing Chemoradiation and Their Caregivers

Sponsor: M.D. Anderson Cancer Center. Phase: NA. Conditions: Head and Neck Carcinoma

full page →ctgov ↗
›RECRUITINGphase readoutNCT07341464: Acceptability and Tolerance Study of Bolus Tube Feed With Food Blends

Sponsor: Société des Produits Nestlé (SPN). Phase: NA. Conditions: Cerebral Palsy (CP), Oncology

full page →ctgov ↗
›ENROLLING_BY_INVITATIONphase readoutNCT07564609: the REMONO-CD and the REMONO-UC Studies

Sponsor: University Hospital, Clermont-Ferrand. Phase: . Conditions: Crohn Disease (CD), Ulcerative Colitis (UC)

full page →ctgov ↗
›NOT_YET_RECRUITINGphase readoutNCT07347236: MyNOURISH: Hydrolysed Collagen Supplementation in Older Adults With Fragility Fractures

Sponsor: Hospital Pengajar Universiti Putra Malaysia. Phase: NA. Conditions: Fragility Fracture

full page →ctgov ↗
›ACTIVE_NOT_RECRUITINGphase readoutNCT06004232: Prenatal Yoga to Prevent Postpartum Depression

Sponsor: Henry Ford Health System. Phase: NA. Conditions: Postpartum Depression

full page →ctgov ↗
›NOT_YET_RECRUITINGphase readoutNCT07473232: Comparison of Platelet-rich Plasma and Activated Cytokine-rich Serum Injection Treatments in Patients With Knee Osteoarthritis. (KOA PRP ACS)

Sponsor: Pamukkale University. Phase: NA. Conditions: Knee Arthritis Osteoarthritis, Platelet Rich Plasma Injection, Conditioned Serum

full page →ctgov ↗
›COMPLETEDphase readoutNCT07522632: Wearable Device to Assess Mobility After Anterior Iliac Grafting Covered With a Regional Block Technique Transversus Abdominis Plane Block

Sponsor: Ain Shams University. Phase: NA. Conditions: Wearable Device, Mobility, Anterior Iliac Grafting, Regional Block Technique, Transversus Abdominis Plane Block

full page →ctgov ↗
›COMPLETEDphase readoutNCT05785832: A Randomized Trial Evaluating Control-IQ+ Technology in Adults With Type 2 Diabetes

Sponsor: Tandem Diabetes Care, Inc.. Phase: NA. Conditions: Type 2 Diabetes Treated With Insulin

full page →ctgov ↗
›NOT_YET_RECRUITINGphase readoutNCT07375732: Transcranial Electrical Stimulation for Noninvasive Study of Menopausal/Perimenopausal Symptoms

Sponsor: Carnegie Mellon University. Phase: NA. Conditions: Menopausal Depression, Menopause Hot Flashes, Menopause, Menopause Related Conditions

full page →ctgov ↗
›RECRUITINGphase readoutNCT01900132: Electrical Impedance Myography: Natural History Studies inNeuromuscular Disorders and Healthy Volunteers

Sponsor: National Institute of Neurological Disorders and Stroke (NINDS). Phase: NA. Conditions: Neuromuscular Disease, Motor Neuron Disease, Inherited Neuromuscular Conditions, Inherited Neuropathies

full page →ctgov ↗
›COMPLETEDphase readoutNCT04128332: Pre-operative Stereotactic Ablative Body Radiotherapy Followed by Immediate Surgery for Pancreatic Cancer

Sponsor: CCTU- Cancer Theme. Phase: NA. Conditions: Cancer of Pancreas

full page →ctgov ↗
›RECRUITINGphase readoutNCT07012798: FOLFOX Combined With Durvalumab (MEDI4736), Bevacizumab, and Stereotactic Body Radiotherapy in Sequential Treatment of Potentially Resectable Locally Advanced Hepatocellular Carcinoma

Sponsor: Tianjin Medical University Cancer Institute and Hospital. Phase: PHASE2. Conditions: Hepatocellular Carcinoma (HCC)

full page →ctgov ↗
← prev
page 82 of 160
next →